期刊文献+

1型多聚二磷酸腺苷核糖合成酶对去甲肾上腺素诱导心肌重构的影响

Critical role of poly(ADP-ribose) polymerase-1 in norepinephrine-induced cardiomyocyte remodeling in cultured rat cardiomyocytes
原文传递
导出
摘要 目的:探讨1型多聚二磷酸腺苷核糖合成酶[poly(ADP-ribose)polymerase-1,PARP-1]对去甲肾上腺素(norepinephrine,NE)诱导培养的大鼠心肌细胞重构过程中的调节作用及其机制。方法:①培养乳鼠心肌细胞,10μmol/LNE刺激心肌细胞24h后,使用实时定量PCR法检测c-fos、ANP、β-MHC、α-MHC基因表达水平;观察抗氧化剂维生素C(VitC)和PARP-1抑制剂3-氨基苯甲酰胺(3-aminobenzamide,3-AB)对上述基因表达的影响。②检测心肌细胞内活性氧(ROS)水平,及PARP活性和PARP-1表达水平的变化。结果:NE诱导心肌细胞内c-fos、ANP、β-MHC基因表达水平明显增加。心肌细胞内ROS产生增加,PARP激活,PARP-1蛋白表达亦显著增加。使用VitC减少ROS产生,抑制了NE诱导的PARP-1活性及表达的增加,NE诱导的c-fos、ANP基因表达也显著降低。3AB可明显减少NE诱导的c-fos、ANP、β-MHC基因的表达及β-MHC/α-MHC的比值。结论:NE刺激心肌细胞增加了细胞内ROS的产生,大量的ROS激活了PARP并使PARP-1的表达水平显著增加,PARP-1参与调节了心肌重构过程胚胎基因c-fos、ANP、β-MHC、α-MHC的异常表达。PARP-1可能是心肌重构过程中的重要调节机制之一。 Objective:To investigate the role of poly (ADP-ribose) polymerase-1 (PARP-1) in NE induced cardiomyocyte remodeling in primary cultured neonatal cardiomyocytes. Method:Primary cultured neonatal cardiomyocytes were divided into 4 groups. Group 1 (control group) received no treatment. Group 2 (NE group) received treatment with NE (10 μmol/L) alone for 24 hours. Group 3 (3AB group) were pretreated with 15 mmol/L PARP inhibitor 3-aminobenzamide (3AB) for 1 hour, followed by additional incubation with NE (10 μmol/L) for 24 hours. Group 4 (VitC group) were pretreated with Vitamin C (1.4mmol/L) followed by NE treatment for 24 hours. Intraeellular ROS level was measured with ROS-sensitive fluorophore DCF-DA by Fluoromax-3 speetrofluorimeter. PARP activity of cultured cells was measured with TCA precipitation method. Expression of PARP-1 in cardiomyocytes was measured with Western blot. mRNA levels of c-fos, atrial natriuretic peptide (ANP), α-myosin heavy chain (MHC) and β-MHC gene were measured with real-time RT-PCR. Result: PARP inhibitor 3AB significantly prevented NE induced 1) increase in PARP activity and PARP-1 expression; 2) increases in β-MHC, c- fos and ANP mRNA levels and ratio of β-MHC/α-MHC in cardiomyocyte; 3) increase in ROS generation. Antioxidant vitamin C significantly prevented NE induced increases in PARP activity and PARP-1 expression in cardiomyocytes; thereby significantly decreased mRNA level of c-fos and ANP. Conclusion:Activation of PARP/PARP- 1 contributes importantly to the abnormal gene expression in NE treated cultured neonatal cardiomyocytes.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2008年第5期389-392,共4页 Journal of Clinical Cardiology
基金 国家自然科学基金资助项目(No:30770881)
关键词 心肌肥大 1型多聚ADP核糖聚合酶 心肌重构 基因表达 Myocardial hypertrophy Poly(ADP-ribose) polymerase Myocardial remodeling Gene expression
  • 相关文献

参考文献17

  • 1TIMOTHY A M, ERIC N O. Toward transcriptional therapies for the failing heart: chemical screens to modulategenes[J]. J Clin Invest, 2005, 115:538- 546.
  • 2DABEK J, KULACH A, MONASTYRSKA-CUP B, et al. Transforming growth factor beta and cardiovascular diseases: the other facet of the "protective cytokine" [J]. Pharmacol Rep, 2006, 58:799-805.
  • 3LIM H, ZHU Y Z. Role of transforming growth factor bata in the progression of heart failure[J]. Cell Mol Life Sci, 2006, 63: 2584-2596.
  • 4LONG C S. Autocrine and paracrine regulation of myocardial cell growth in vitro: the TGF beta paradigin[J]. Trends CardiovascMed, 1996, 6: 217-222.
  • 5PAATTEN M, HARTOGENSIS W E, LONG C S. Interleukin-1 beta is a negative transcriptional regulator of alpha adrenergic induced gene expression in cultured cardiac myocytes[J]. J Biol Chem, 1996, 271: 21134-21141.
  • 6BRIEST W, HOLZL A, RASSLER B, et al. Significance of matrix metalloproteinases in norepinephrine-induced remodelling of rat hearts[J]. Cardiovasc Res, 2003, 57:379-387.
  • 7BRIEST W, HOLZL A, RASSLER B, et al. Cardiac remodeling after long term norepinephrine treatment in rats[J]. Cardiovasc Res, 2001, 52:265-273.
  • 8VIRAG L, SZABO C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors[J]. Pharmacol Rev, 2002, 54:375-429.
  • 9MOLNAR A, TOTH A, BAGI Z, et al. Activation of poly (ADP-ribose) polemerase pathway in human heart failure[J]. Mol Med, 2006, 12: 143-152.
  • 10XIAO C Y, CHEN M, ZSENGELLER Z, et al. Poly (ADP-Ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure[J]. J Pharmacol Exp Ther, 2005, 312:891-898.

二级参考文献22

  • 1[1]VIRAG L,SZABO C.The therapeutic potential of poly (ADP-ribose) polymerase inhibitors[J].Pharmacol Rev,2002,54:375-429.
  • 2[2]CARDAROPOLI S,SILVAGNO F,MORRA E,et al.Infectious and inflammatory stimuli decrease endothelial nitric oxide sythase activity in vitro[J].J hypertens,2003,21:21032-2110.
  • 3[3]HIDEMITSU N,HIROSHI N,NOBUKAZU K.Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-κB dependent gene expression in primary cultured mouse glial cells[J].J Biol Chem,2004,279:42774-42778.
  • 4[4]KOH O,AKIRA M.Cytokine gene expression after myocardial infarction in rat hearts:possible implication in left ventricular remoldeling[J].Circulation,1998,98:149-156.
  • 5[5]CSABA S,PáL P,ZSUZUANNA Z,et al.Angiotensin Ⅱ-Mediated endothelial dysfunction:role of poly (ADP-ribose) polymerase activation[J].Mol Med,2004,10:28-35.
  • 6[6]PACHER P,MABLEY J G,SORIANO F G,et al.Activation of poly (ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging[J].Int J Mol Med,2002,9:659-664.
  • 7[7]BAKER K M,BOOZ G W,DOSTAL D E.Cardiac actions of angiotensin Ⅱ role of an intracardi-acrenin-angiotensin system[J].Annu Rev Physiol,1992,54:227L-241L.
  • 8[8]PILLAI J B,GUPTA M,RAJAMOHAN S B,et al.Related Articles,Links Poly (ADP-ribose) polymerase-1-deficient mice are protected from angiotensin Ⅱ-induced cardiac hypertrophy[J].Am J Physiol Heart Circ Physiol,2006,291:H1545-H1553.
  • 9[10]HUANG K,TIDYMAN W E,LE K U,et al.Analysis of nucleotide sequence-dependent DNA binding of poly (ADP-ribose) polymerase in a purified system[J].Biochemistry,2004,43:217-223.
  • 10AME J C, ROLLI V, SCHREIBER V, et al. PARP-2, a novel mammalian DNA damage-dependent poly (ADP-ribose) polymerase[J]. J Biol Chem, 1999,274 : 17860-17868.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部